Clinical Trial Update: Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the effect and safety of Marealis RPC in adults with prehypertension, reporting on blood pressure-related outcomes and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prehypertension

Drugs mentioned

• Marealis RPC (Refined Peptide Concentrate)

Snippet

Sponsor: KGK Science Inc. | Conditions: Prehypertension | Phase 2 | Status: COMPLETED